S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/Baker Bros Advisors/Q2 2025

Baker Bros Advisors

Periodo: Q2 2025 · Depositato: 2025-08-14
Vedi su SEC EDGAR
AUM
$10.31B
Valore totale del portafoglio
Posizioni
89
Titoli dichiarati
Prima Posizione
ONC
20.7% $2.13B
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2025-08-14) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
ONCBeOne Medicines Ltd.$2.13B20.66%$242.07$297.65+23.0%
20.7%
INCYIncyte Corporation$2.09B20.31%$68.10$116.86+71.6%
20.3%
ACADACADIA Pharmaceuticals Inc.$925.3M8.98%$21.57$25.97+20.4%
9.0%
INSMInsmed Incorporated$776.2M7.53%$100.64$111.60+10.9%
7.5%
SMMTSummit Therapeutics Inc.$717.6M6.96%$21.28$15.42-27.5%
7.0%
MDGLMadrigal Pharmaceuticals, Inc.$598.0M5.80%$302.64$528.10+74.5%
5.8%
RYTMRhythm Pharmaceuticals, Inc.$354.1M3.44%$63.19$114.17+80.7%
3.4%
RVMDRevolution Medicines, Inc.$344.5M3.34%$36.79$189.24+414.4%
3.3%
KYMRKymera Therapeutics, Inc.$290.3M2.82%$43.64$113.51+160.1%
2.8%
ALKSAlkermes plc$183.4M1.78%$28.61$54.58+90.8%
1.8%
REPLReplimune Group, Inc.$102.6M1.00%$9.29$11.58+24.6%
1.0%
RAREUltragenyx Pharmaceutical Inc.$100.8M0.98%$36.36$33.47-8.0%
1.0%
EWTXEdgewise Therapeutics, Inc.$95.8M0.93%$13.11$39.56+201.8%
0.9%
ABCLAbCellera Biologics Inc.$94.4M0.92%$3.43$8.11+136.4%
0.9%
IMVTImmunovant, Inc.$87.3M0.85%$16.00$38.79+142.4%
0.8%
GRALGRAIL, Inc.$83.8M0.81%$51.42$69.11+34.4%
0.8%
KNSAKiniksa Pharmaceuticals International, plc$78.2M0.76%$27.67$64.53+133.2%
0.8%
BCYCBicycle Therapeutics plc$75.7M0.73%$6.95$4.35-37.4%
0.7%
IMCRImmunocore Holdings plc$72.9M0.71%$31.38$32.50+3.6%
0.7%
CELCCelcuity Inc.$72.8M0.71%$13.35$107.95+708.6%
0.7%
KODKodiak Sciences Inc.$64.6M0.63%$3.73$38.54+933.2%
0.6%
IMTXImmatics N.V.$54.7M0.53%$5.38$9.95+84.9%
0.5%
STOKStoke Therapeutics, Inc.$52.6M0.51%$11.35$32.70+188.1%
0.5%
DNLIDenali Therapeutics Inc.$52.2M0.51%$13.99$25.83+84.6%
0.5%
GPCRStructure Therapeutics Inc.$52.0M0.50%$20.74$53.45+157.7%
0.5%
IDYAIDEAYA Biosciences, Inc.$44.5M0.43%$21.02$37.65+79.1%
0.4%
NRIXNurix Therapeutics, Inc.$44.2M0.43%$11.39$23.97+110.5%
0.4%
ROIVRoivant Sciences Ltd.$42.5M0.41%$11.27$35.13+211.7%
0.4%
BNTXBioNTech SE$39.3M0.38%$106.47$97.54-8.4%
0.4%
TRDAEntrada Therapeutics, Inc.$32.7M0.32%$6.72$7.72+14.9%
0.3%

Attività Trimestre su Trimestre

Q2 2025 vs. Q1 2025

Nuove Posizioni (8)

TickerEmittenteNozionale
VRDNViridian Therapeutics, Inc.$24.4M
BPMCBlueprint Medicines Corporation$16.1M
ARWRArrowhead Pharmaceuticals, Inc.$14.8M
DNTHDianthus Therapeutics, Inc.$14.7M
CDTXCidara Therapeutics, Inc.$11.1M
ACLXArcellx, Inc.$11.0M
NUVLNuvalent, Inc.$11.0M
SYRESpyre Therapeutics, Inc.$9.4M

Posizioni Chiuse (8)

TickerEmittenteNozionale
Insmed Incorporated$101.6M
CRSPCRISPR Therapeutics AG$22.3M
CNTACentessa Pharmaceuticals plc$17.6M
TSVT2seventy bio, Inc.$12.3M
BCAXBicara Therapeutics Inc.$10.9M
IONSIonis Pharmaceuticals, Inc.$10.8M
DYNDyne Therapeutics, Inc.$7.0M
RGLSRegulus Therapeutics Inc.$4.7M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
BNTXBioNTech SE$35.2M+719.3%-8.4%
GPCRStructure Therapeutics Inc.$45.8M+593.9%+157.7%
IRONDisc Medicine, Inc.$14.0M+337.4%
NTLAIntellia Therapeutics, Inc.$20.5M+315.4%
CLDXCelldex Therapeutics, Inc.$9.1M+168.7%
MRUSMerus N.V.$20.8M+157.0%
PRAXPraxis Precision Medicines, Inc.$16.4M+108.0%
IDYAIDEAYA Biosciences, Inc.$27.1M+99.5%+79.1%

Ridotte (8)

TickerEmittenteNozionaleVar. Azioni
CADLCandel Therapeutics, Inc.$-12.0M-85.4%
ARGXargenx SE$-25.2M-51.4%
RCKTRocket Pharmaceuticals, Inc.$-6.0M-49.7%
AKROAkero Therapeutics, Inc.$-4.9M-40.8%
CERSCerus Corporation$-8.7M-33.4%
NGNENeurogene Inc.$-2.6M-33.3%
FATEFate Therapeutics, Inc.$0.2M-23.7%
DSGNDesign Therapeutics, Inc.$-1.0M-1.8%
Torna agli Hedge Fund